Evidence map›Paper›PMID 41120665›Full record

ArticleNature biotechnology2026

AlphaDIA enables DIA transfer learning for feature-free proteomics.

Georg Wallmann, Patricia Skowronek, Vincenth Brennsteiner, Mikhail Lebedev, Marvin Thielert, Sophia Steigerwald, Mohamed Kotb, Oscar Despard, Tim Heymann, Xie-Xuan Zhou and 6 more

Abstract read
In one paragraph

Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Open-Source and FAIR Research Software for Proteomics.Journal of proteome research · 2025
    Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Georg WallmannProteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.ORCID http://orcid.org/0000-0003-4749-3730
Patricia SkowronekProteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.ORCID http://orcid.org/0000-0002-8441-6067
Vincenth BrennsteinerProteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
Mikhail LebedevProteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.ORCID http://orcid.org/0009-0008-3646-7899
Marvin ThielertProteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
Sophia SteigerwaldProteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
Mohamed KotbProteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
Oscar DespardProteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
Tim HeymannProteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.ORCID http://orcid.org/0000-0002-6984-6894
Xie-Xuan ZhouProteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
Maximilian T StraussProteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID http://orcid.org/0000-0003-3320-6833
Constantin AmmarProteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
Sander WillemsProteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.ORCID http://orcid.org/0000-0002-7124-610X
Magnus SchwörerProteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.
Wen-Feng ZengProteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany. wzeng@biochem.mpg.de.ORCID http://orcid.org/0000-0003-4325-2147
Matthias MannProteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany. mmann@biochem.mpg.de.ORCID http://orcid.org/0000-0003-1292-4799

Funding

EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 874839
6 · The paper itself

Abstract

The scale of data generated for mass-spectrometry-based proteomics and modern acquisition strategies poses a challenge to bioinformatic analysis. Search engines need to make optimal use of the data for biological discoveries while remaining statistically rigorous, transparent and performant. Here we present alphaDIA, a modular open-source search framework for data-independent acquisition (DIA) proteomics. We developed a feature-free identification algorithm that performs machine learning directly on the raw signal and is particularly suited for detecting patterns in data produced by time-of-flight instruments. Benchmarking demonstrates competitive identification and quantification performance. While the method supports empirical spectral libraries, we propose a search strategy named DIA transfer learning that uses fully predicted libraries. This entails continuously optimizing a deep neural network for predicting machine-specific and experiment-specific properties, enabling the generic DIA analysis of any post-translational modification. AlphaDIA provides a high performance and accessible framework running locally or in the cloud, opening DIA analysis to the community.

Indexed as

ProteomicsSoftwareAlgorithmsComputational BiologyDatabases, ProteinMachine LearningMass SpectrometryNeural Networks, Computer

Identifiers

PMID41120665
PMCPMC13368584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.